GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (OTCPK:HLNCF) » Definitions » Beneish M-Score

HLNCF (Haleon) Beneish M-Score : -2.53 (As of Mar. 25, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.53 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Haleon's Beneish M-Score or its related term are showing as below:

HLNCF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.71   Med: -2.59   Max: -2.43
Current: -2.53

During the past 6 years, the highest Beneish M-Score of Haleon was -2.43. The lowest was -3.71. And the median was -2.59.


Haleon Beneish M-Score Historical Data

The historical data trend for Haleon's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Beneish M-Score Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial - -2.43 -3.71 -2.70 -2.53

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.70 - - - -2.53

Competitive Comparison of Haleon's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Haleon's Beneish M-Score falls into.



Haleon Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Haleon for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1383+0.528 * 0.9827+0.404 * 0.9685+0.892 * 0.9926+0.115 * 0.9684
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.015+4.679 * -0.025033-0.327 * 1.0673
=-2.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was $2,407 Mil.
Revenue was $14,201 Mil.
Gross Profit was $8,627 Mil.
Total Current Assets was $7,229 Mil.
Total Assets was $43,382 Mil.
Property, Plant and Equipment(Net PPE) was $2,429 Mil.
Depreciation, Depletion and Amortization(DDA) was $410 Mil.
Selling, General, & Admin. Expense(SGA) was $5,628 Mil.
Total Current Liabilities was $7,348 Mil.
Long-Term Debt & Capital Lease Obligation was $10,891 Mil.
Net Income was $1,823 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $2,909 Mil.
Total Receivables was $2,130 Mil.
Revenue was $14,306 Mil.
Gross Profit was $8,541 Mil.
Total Current Assets was $6,099 Mil.
Total Assets was $43,108 Mil.
Property, Plant and Equipment(Net PPE) was $2,408 Mil.
Depreciation, Depletion and Amortization(DDA) was $391 Mil.
Selling, General, & Admin. Expense(SGA) was $5,586 Mil.
Total Current Liabilities was $5,873 Mil.
Long-Term Debt & Capital Lease Obligation was $11,108 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2407.08 / 14201.011) / (2130.38 / 14306.329)
=0.169501 / 0.148912
=1.1383

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8540.506 / 14306.329) / (8627.054 / 14201.011)
=0.596974 / 0.607496
=0.9827

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (7228.824 + 2428.571) / 43381.795) / (1 - (6098.734 + 2407.595) / 43107.595)
=0.777386 / 0.802672
=0.9685

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=14201.011 / 14306.329
=0.9926

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(391.139 / (391.139 + 2407.595)) / (409.608 / (409.608 + 2428.571))
=0.139756 / 0.144321
=0.9684

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5628.319 / 14201.011) / (5586.076 / 14306.329)
=0.396332 / 0.390462
=1.015

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10891.277 + 7347.661) / 43381.795) / ((11107.595 + 5873.418) / 43107.595)
=0.420428 / 0.393922
=1.0673

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1823.009 - 0 - 2908.976) / 43381.795
=-0.025033

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Haleon has a M-score of -2.53 suggests that the company is unlikely to be a manipulator.


Haleon Business Description

Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon Headlines